Stocks · Health care · Biological Products, (No Diagnostic Substances)

Editas Medicine, Inc.

EDIT Clue Score47

United States Fiscal year ends December CIK 0001650664 Results filed 5 Aug 2026

Add to watchlist

By person

5 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Gilmore Neil O'Neill

CEO

—

$80.06K (4) scheduled

−$80.06K

243,189

0.1583%

$738.61K

−22.5%

Linda Burkly

EVP, Chief Scientific Officer

—

$20.33K (5) scheduled

−$20.33K

61,660

0.0401%

$187.27K

−21.9%

Amy Parison

SVP, Chief Financial Officer

—

$6.33K (5) scheduled

−$6.33K

13,839

0.0090%

$42.03K

−22.9%

Baisong Mei

EVP, Chief Medical Officer

—

133,354

0.0868%

$405.02K

−0.4%

Erick Lucera

EVP, Chief Financial Officer

—

112,720

0.0734%

$342.35K

−3.5%

Editas Medicine, Inc.

What the insiders did Scheduled selling only

By person